Fulvestrant Injection and Temozolomide Intravenous

• Generic Name: fulvestrant
• Dosage Forms: injection
• Other Brand Names: Faslodex

Fulvestrant is used in postmenopausal women with hormone-related breast cancer that is advanced or has spread to other parts of the body (metastatic).

Fulvestrant is used alone or in combination with another medicine called ribociclib (Kisqali) to treat HR-positive, HER2-negative breast cancer in:

• women with no prior treatment; or

• women whose cancer has progressed after treatment with anti-estrogen medication.

Fulvestrant is used in combination with palbociclib (Ibrance) or abemaciclib (Verzenio) when the cancer has progressed after treatment with anti-estrogen medication.

Fulvestrant may also be used for purposes not listed in this medication guide.

• Generic Name: temozolomide
• Dosage Forms: n.a.
• Other Brand Names: Temodar

Temozolomide injection is used to treat specific types of brain cancer (eg, glioblastoma multiforme, anaplastic astrocytoma) in patients whose tumors have returned or whose tumors have just been diagnosed. It belongs to the group of medicines known as antineoplastics (cancer medicines).

Temozolomide interferes with the growth of cancer cells, which are then destroyed by the body. Since the growth of normal body cells may also be affected by temozolomide injection, other side effects may occur. Some of these may be serious and must be reported to your doctor. Some side effects may not occur for months or years after the medicine is used.

Before you begin treatment with temozolomide injection, you and your doctor should talk about the benefits temozolomide will do as well as the risks of using it.

Temozolomide is to be given only by or under the immediate supervision of your doctor.